RECENT NEWS

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched its refreshed strategic direction, with new CEO Lawrence Tallon saying the agency will focus on safety, accelerated access and innovation as it looks to become a global leader in risk-proportionate regulation.

The College of American Pathologists (CAP) is to launch a new virtual artificial intelligence (AI) platform to give pathologists experience with digital technology.

Enalees, a French pioneer in rapid PCR tests for animal health, has launched Rhéa, its new range of rapid molecular diagnostic tests for cattle, sheep and goats.

Greater diversity is needed in genetic research to make genomics’ use in cancer care and screening more accurate and reliable for all, according to a new study.

From 16 June 2025, a landmark reform of how medical devices are regulated in Great Britain takes effect, as part of a Medicines and Healthcare products Regulatory Agency (MHRA) broader transformation of the UK’s medical device regulatory framework.

The 10 Year Health Plan will speed up clinical research with changes to clinical trials, aiming to benefit patients by introducing cutting-edge treatments years earlier and making the UK a hotbed of innovation.

QIAGEN and Incyte have announced a new global collaboration to develop a novel diagnostic panel to support Incyte’s extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms (MPNs), a group of rare blood cancers.

The Royal College of Pathologists (RCPath) has welcomed the publication of the Public Accounts Committee's report following its inquiry on antimicrobial resistance (AMR) and its recognition of the vital role of medical microbiology and virology.

The Institute of Biomedical Science has proclaimed Biomedical Science Day 2025 a huge success, with 320 events reaching thousands for the biggest celebratory day yet.

Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to advancing precision medicine. This perspective comes as organisations across the sector prioritise modernisation and seek trusted partners to support their transformation, according to new research.

Medical AI firm Paige has announced a new partnership with the Breast International Group (BIG), a leading international non-profit organisation dedicated to breast cancer research, to conduct collaborative research aimed at improving breast cancer diagnosis, treatment, and patient outcomes.

Cleanroom microbiology firm Cherwell has introduced a new range of plated prepared media designed to deliver sample security, data integrity, and optimised workflow in microbial monitoring.

The Royal College of Pathologists has launched a new Patient Safety Steering Group (PSSG), bringing together expert voices from across the profession to help implement the College’s Patient Safety and Quality Strategy 2024–2029.

A state-of-the-art centre has been opened that could help clinicians advance personalised medicine by understanding complex biological systems. The new Multi-Omics Research Laboratory at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust could also support the development of new diagnostic tests.

Linear Diagnostics has been awarded funding of £1 million to finalise the development of a rapid test for sexually transmitted infections (STIs), in partnership with the NIHR HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation and the North East Innovation Lab, part of Newcastle Hospitals.

More NHS patients will receive test results - along with appointment reminders and screening invitations - directly to their smartphones following a £50million upgrade to the NHS App which aims to make it easier for patients to access care.

Quantico, the diagnostic platform developed by Viscera Technologies, was the runner-up in the ‘Best Digital Health Solution’ category at the Prix Galien UK Awards, which were hosted at the Natural History Museum in London.

A technology project to support the transformation of pathology services across Northern Ireland has been completed, with the go-live of the Clinisys WinPath laboratory information management system (LIMS) at the final two health and social care trusts.

Diagnostics firm QuidelOrtho has announced a refocusing of its molecular diagnostics strategy, to include the full acquisition of LEX Diagnostics and discontinuing the company's Savanna platform development.

A new digital hub in Leeds is being launched by the Medicines and Healthcare products Regulatory Agency (MHRA), marking a significant step in the agency’s long-term commitment to advancing innovation and strengthening its presence across the UK.